InMed Pharmaceuticals Inc. (INM) Reports Q2 Loss of $0.37

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. ABBV
3. REGN
4. CL
5. LYB
6. TFII
7. LITE
8. NVT
9. BP
10. SPY

Go back to InMed Pharmaceuticals Inc. (INM) Reports Q2 Loss of $0.37

InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results

February 11, 2021 7:30 AM EST

VANCOUVER, BC, Feb. 11, 2021 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol ("CBN"), today reported financial results for the second quarter of fiscal year 2021 ("2Q21") which ended December 31, 2020.

Conference Call & Webcast1:

Thursday,... More